AIDS Alert International: Consider postexposure STD screening
Consider postexposure STD screening
By Carol Kemper, MD
Clinical Associate Professor of Medicine
Stanford University
Stanford, CA
|
Travelers are an important risk group for sexually transmitted diseases (STDs). Various surveys suggest that anywhere from 5% to 50% of travelers engage in sexual activity when traveling, the majority of which is unprotected. A recent survey of blood and body fluid exposures in international travelers found that sexual activity with a new partner was the most frequent form of risk behavior in travelers (9%), followed by sharing hygienic items (toothbrushes, razors, etc.) (5%), percutaneously administered traditional medical therapy (injections, IVs) (3.2%), acupuncture (1%), body piercing and tattooing (0.5%), and abrasive injuries (0.5%).1 Clinicians should be aware of those factors that increase the likelihood of sexual activity abroad, including male sex, unmarried status, younger age, traveling alone, a history of unprotected/casual sex at home, travel to a recurrent destination, and alcohol use.
While education and counseling are important components of prevention, written materials (which can be read at a later time) appear to have the greatest effect. The distribution of free condoms and fun lubricants in travel clinics (similar to what we offer in our HIV/AIDS clinic) may also help promote the idea of safer sex.
These studies have also wisely suggested that physicians should schedule travelers at higher risk for sexual behavior for follow-up STD screening when they return, even if they are asymptomatic or admit to condom use. This would include urine LCR/PCR for gonorrhea and chlamydia and serologic studies for HIV, HBV, and syphilis. Given the frequency of blood and body fluid exposures, vaccination for hepatitis B should be more broadly encouraged in travelers, especially homosexuals, frequent travelers, sex tourists, and people who plan to be abroad for more than 3 months.
Reference
1. Matteelli A, Carosi G. Clin Infect Dis 2001;32:1063-1067; Correia JJ, et al. J Travel Med 2001; 8:263-266.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.